Speed Medical results, Q1 2025
Net profit, assets, equity and cash flow for Q1 2025, against the same period a year earlier, from the published financial statements.
Net profit-15.68 millionEGP · +38.4% vs the same period a year earlier
Total assets417 millionEGP · −23.8% vs the same period a year earlier
Shareholders' equity210 millionEGP · −25.0% vs the same period a year earlier
Operating cash flow-444 thousandEGP · −104.1% vs the same period a year earlier
In short
- Speed Medical's net profit for Q1 2025 was about -15.68 million EGP, up +38.4% from -25.45 million EGP in Q1 2024.
- Total assets at the end of Q1 2025 were about 417 million EGP, and shareholders' equity about 210 million EGP.
- Operating cash flow for Q1 2025 was negative at 444 thousand EGP.
Key lines against the same period a year earlier
This periodQ1 2024Change
Net profit-15.68 million-25.45 million+38.4%
Gross profit308 thousand-6.33 million+104.9%
Total assets417 million547 million−23.8%
Total liabilities207 million266 million−22.5%
Shareholders' equity210 million281 million−25.0%
Total liabilities and equity417 million547 million−23.8%
Operating cash flow-444 thousand10.87 million−104.1%
Investing cash flow—-136 thousand—
Financing cash flow-29.41 million-12.26 million−140.0%
Net change in cash-29.86 million-1.53 million−1855.7%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy